Deal Making

Featured on Deal Making

Performance Cell acquired by PE, renamed Cellipont Bioservices
Deal-Making
Performance Cell acquired by PE, renamed Cellipont BioservicesPerformance Cell acquired by PE, renamed Cellipont Bioservices

CDMO Performance Cell Manufacturing has been acquired by private equity firm Great Point Partners and will operate as Cellipont Bioservices.

byMillie Nelson, Editor
Jan 14, 2022
|
2 Min Read
Danaher: $10bn+ war chest in 2022 but sees no gaps in bioprocessing
Upstream & Downstream Processing
Danaher: $10bn+ war chest in 2022 but sees no gaps in bioprocessingDanaher: $10bn+ war chest in 2022 but sees no gaps in bioprocessing
byDan Stanton
Jan 13, 2022
2 Min Read
Takeda drives immuno-oncology portfolio with Adaptate buy
Deal-Making
Takeda drives immuno-oncology portfolio with Adaptate buyTakeda drives immuno-oncology portfolio with Adaptate buy
byMillie Nelson
Jan 12, 2022
2 Min Read
Pfizer bolsters mRNA through deals with Acuitas, Codex, and Beam
Deal-Making
Pfizer bolsters mRNA through deals with Acuitas, Codex, and BeamPfizer bolsters mRNA through deals with Acuitas, Codex, and Beam
byMillie Nelson
Jan 11, 2022
3 Min Read
2022 begins with proliferation of advanced therapy CDMO investments
Deal-Making
2022 begins with proliferation of advanced therapy CDMO investments2022 begins with proliferation of advanced therapy CDMO investments
byDan Stanton
Jan 11, 2022
4 Min Read
Cell and gene therapy exits from Sanofi and AvroBio
Therapeutic Class
Cell and gene therapy exits from Sanofi and AvroBioCell and gene therapy exits from Sanofi and AvroBio
byDan Stanton
Jan 11, 2022
2 Min Read

More from Deal Making

ChargePoint enters liquid and fluid space with Terracon buy
Deal-Making
ChargePoint enters liquid and fluid space with Terracon buy
ChargePoint enters liquid and fluid space with Terracon buy
Jan 10, 2022
|
2 Min Read
byMillie Nelson, Editor
Merck KGaA to acquire Exelead in $780m deal
Deal-Making
Merck KGaA to acquire Exelead in $780m deal
Merck KGaA to acquire Exelead in $780m deal
Jan 7, 2022
|
2 Min Read
byMillie Nelson, Editor
Univercells adds DNA synthesis through SynHelix buy
Deal-Making
Univercells adds DNA synthesis through SynHelix buy
Univercells adds DNA synthesis through SynHelix buy
Jan 6, 2022
|
1 Min Read
byBPI Staff
Thermo Fisher buys recombinant protein maker PeproTech for $1.85bn
Deal-Making
Thermo Fisher buys recombinant protein maker PeproTech for $1.85bn
Thermo Fisher buys recombinant protein maker PeproTech for $1.85bn
Jan 6, 2022
|
2 Min Read
byDan Stanton, Editorial director
Pfizer and BioNTech to develop first mRNA shingles vax
Deal-Making
Pfizer and BioNTech to develop first mRNA shingles vax
Pfizer and BioNTech to develop first mRNA shingles vax
Jan 6, 2022
|
2 Min Read
byMillie Nelson, Editor
Bioanalytics booster: Sartorius takes stake in Automated Lab Solutions
Upstream & Downstream Processing
Bioanalytics booster: Sartorius takes stake in Automated Lab Solutions
Bioanalytics booster: Sartorius takes stake in Automated Lab Solutions
Jan 4, 2022
|
2 Min Read
byDan Stanton, Editorial director
Novartis to boost gene therapy pipeline through $800m Gyroscope buy
Therapeutic Class
Novartis to boost gene therapy pipeline through $800m Gyroscope buy
Novartis to boost gene therapy pipeline through $800m Gyroscope buy
Jan 4, 2022
|
2 Min Read
byDan Stanton, Editorial director
Sanofi to buy Amunix for $1bn
Deal-Making
Sanofi to buy Amunix for $1bn
Sanofi to buy Amunix for $1bn
Dec 21, 2021
|
2 Min Read
byMillie Nelson, Editor
Oxford Biomedica strikes extended supply deal with Novartis
Deal-Making
Oxford Biomedica strikes extended supply deal with Novartis
Oxford Biomedica strikes extended supply deal with Novartis
Dec 17, 2021
|
2 Min Read
byMillie Nelson, Editor
Bora Pharmaceuticals enters partnership to expand CDMO presence
Deal-Making
Bora Pharmaceuticals enters partnership to expand CDMO presence
Bora Pharmaceuticals enters partnership to expand CDMO presence
Dec 14, 2021
|
1 Min Read
byMillie Nelson, Editor
Doer to develop multi-specific biotherapeutics using Lonza’s technology
Deal-Making
Doer to develop multi-specific biotherapeutics using Lonza’s technology
Doer to develop multi-specific biotherapeutics using Lonza’s technology
Dec 13, 2021
|
1 Min Read
byMillie Nelson, Editor
Ampersand backs Alliance Pharma and plans 'aggressive' growth plan
Deal-Making
Ampersand backs Alliance Pharma and plans 'aggressive' growth plan
Ampersand backs Alliance Pharma and plans 'aggressive' growth plan
Dec 13, 2021
|
2 Min Read
byGareth Macdonald
BrainStorm’s cell therapy: Catalent high on NurOwn supply
Deal-Making
BrainStorm’s cell therapy: Catalent high on NurOwn supply
BrainStorm’s cell therapy: Catalent high on NurOwn supply
Dec 8, 2021
|
2 Min Read
byDan Stanton, Editorial director
Resilience buys cell free synthesis tech firm SwiftScale Biologics
Deal-Making
Resilience buys cell free synthesis tech firm SwiftScale Biologics
Resilience buys cell free synthesis tech firm SwiftScale Biologics
Dec 6, 2021
|
2 Min Read
byGareth Macdonald
Downstream dealmaking: Donaldson buys Solaris, Ecolab closes on Purolite
Deal-Making
Downstream dealmaking: Donaldson buys Solaris, Ecolab closes on Purolite
Downstream dealmaking: Donaldson buys Solaris, Ecolab closes on Purolite
Dec 2, 2021
|
2 Min Read
byDan Stanton, Editorial director
Sanofi boosts vaccine pipeline with Origimm buy
Deal-Making
Sanofi boosts vaccine pipeline with Origimm buy
Sanofi boosts vaccine pipeline with Origimm buy
Dec 1, 2021
|
2 Min Read
byMillie Nelson, Editor
CDMO round-up: Lonza, Abzena, and Samsung deals
Deal-Making
CDMO round-up: Lonza, Abzena, and Samsung deals
CDMO round-up: Lonza, Abzena, and Samsung deals
Nov 29, 2021
|
2 Min Read
byMillie Nelson, Editor
Generate Biomedicines raises $370m to advance AI drug discovery tech
Upstream & Downstream Processing
Generate Biomedicines raises $370m to advance AI drug discovery tech
Generate Biomedicines raises $370m to advance AI drug discovery tech
Nov 22, 2021
|
1 Min Read
byGareth Macdonald
Ins & Outs: Filling gaps at Pfizer and the FDA
Deal-Making
Ins & Outs: Filling gaps at Pfizer and the FDA
Ins & Outs: Filling gaps at Pfizer and the FDA
Nov 18, 2021
|
3 Min Read
byMillie Nelson, Editor
Novo Nordisk to add RNAi engine in $3.3bn Dicerna buy
Therapeutic Class
Novo Nordisk to add RNAi engine in $3.3bn Dicerna buy
Novo Nordisk to add RNAi engine in $3.3bn Dicerna buy
Nov 18, 2021
|
2 Min Read
byDan Stanton, Editorial director
Inceptor snaps up Arranta plant in Florida
Facilities & Capacity
Inceptor snaps up Arranta plant in Florida
Inceptor snaps up Arranta plant in Florida
Nov 17, 2021
|
2 Min Read
byDan Stanton, Editorial director
CGT Catapult partners to overcome barriers in ATMP industry
Deal-Making
CGT Catapult partners to overcome barriers in ATMP industry
CGT Catapult partners to overcome barriers in ATMP industry
Nov 16, 2021
|
2 Min Read
byMillie Nelson, Editor
Ins and outs: AGC to address CGT needs through CBO hire
Deal-Making
Ins and outs: AGC to address CGT needs through CBO hire
Ins and outs: AGC to address CGT needs through CBO hire
Nov 15, 2021
|
5 Min Read
byMillie Nelson, Editor
Masco Group bolsters engineering tech with KeyPlants buy
Deal-Making
Masco Group bolsters engineering tech with KeyPlants buy
Masco Group bolsters engineering tech with KeyPlants buy
Nov 15, 2021
|
2 Min Read
byMillie Nelson, Editor
CJ Cheiljedang diversifies biz with $226m Batavia buy
Deal-Making
CJ Cheiljedang diversifies biz with $226m Batavia buy
CJ Cheiljedang diversifies biz with $226m Batavia buy
Nov 10, 2021
|
2 Min Read
byMillie Nelson, Editor
MilliporeSigma to support SaudiVax in developing first halal vaccine
Deal-Making
MilliporeSigma to support SaudiVax in developing first halal vaccine
MilliporeSigma to support SaudiVax in developing first halal vaccine
Nov 9, 2021
|
2 Min Read
byMillie Nelson, Editor
Ins and outs: Avid create viral vector position to lead CGT expansion
Deal-Making
Ins and outs: Avid create viral vector position to lead CGT expansion
Ins and outs: Avid create viral vector position to lead CGT expansion
Nov 8, 2021
|
2 Min Read
byMillie Nelson, Editor
Emergent taking $180m hit as US Gov scraps CDMO contract
Deal-Making
Emergent taking $180m hit as US Gov scraps CDMO contract
Emergent taking $180m hit as US Gov scraps CDMO contract
Nov 5, 2021
|
3 Min Read
byDan Stanton, Editorial director
Vaccine partnership results in optimized mRNA process, says BioNet
Facilities & Capacity
Vaccine partnership results in optimized mRNA process, says BioNet
Vaccine partnership results in optimized mRNA process, says BioNet
Nov 4, 2021
|
1 Min Read
byMillie Nelson, Editor
Lonza bags Codiak’s exosome plant in $65m deal
Deal-Making
Lonza bags Codiak’s exosome plant in $65m deal
Lonza bags Codiak’s exosome plant in $65m deal
Nov 3, 2021
|
2 Min Read
byMillie Nelson, Editor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe